I'm in the same boat as you regarding everything you stated. Haven't heard anything re: ATM offering but company hasn't hit it yet. Either waiting until share price is much higher or in desperate times?
For me, as soon as the cash situation for a bio company starts popping up in conversation it means it's an issue and I tend to not trust them when they state how much they have and for a specific period. In my recollection, most bio companies raise well before they are expected to even though they say they're fine.
I can't seem to find any information on it but I tend to trust what Sheff states. No reason to make it up unless he's mistaken somehow.
Nothing that I'm aware of until fibro data. Even with positive results there, I don't see the stock moving very high. They are in a financial pickle of a situation and nobody is going to jump in until that's cleared up. As some have stated, military may step in and fund the PTSD data which would be fantastic to see. Let's cross our fingers and hope it happens.
So if they haven't hit the ATM yet, that probably means some large institution was unloading the day and day after announcing PTSD results. 6+ million shares in two days is not retail.
You would think/assume that the Nasdaq site would be the most reliable and correct. It's the same scenario for many stocks, where one site shows something completely different than another and nobody seems to know which one is correct.
How can you not be demoralized here? I'm averaged in at a much higher price and it's not reassuring that the share price continues to go down, especially after issuing somewhat positive PTSD results.
In an ideal world they won't raise capital until a spike, but who is to say this is going to see any spikes in the near future? After seeing what happened with PTSD, a spike from positive fibro isn't a guaranteed thing.
I am at the point where I really can't see what possibly moves this back up. PIII fibro, maybe, but the terrible cash situation and uncertainty about the PTSD trial and having to run a much larger trial is going to hang over the share price head for a long time here. This has now turned into a very long hold for many people who never planned on holding for long.